|
|
||||||||

T Cells to the Synthetic Polypeptide Poly-Glu50Tyr50 1


*
Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206;
Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, NY 10010;
Department of Dermatology, Chung-Ang University Pil-dong, Chung-ku, Seoul, South Korea; and
§
Department of Dermatology, University of Colorado Health Sciences Center, Denver, CO 80262
Random heterocopolymers of glutamic acid and tyrosine (pEY) evoke
strong, genetically controlled immune responses in certain mouse
strains. We found that pE50Y50 also stimulated
polyclonal proliferation of normal 
, but not
ß, T cells.
Proliferation of 
T cells did not require prior immunization with
this Ag nor the presence of
ß T cells, but was enhanced by IL-2.
The 
T cell response proceeded in the absence of accessory cells,
MHC class II, ß2-microglobulin, or TAP-1, suggesting that
Ag presentation by MHC class I/II molecules and peptide processing are
not required. Among normal splenocytes, as with 
T cell
hybridomas, the response was strongest with V
1+ 
T
cells, and in comparison with related polypeptides,
pE50Y50 provided the strongest stimulus for
these cells. TCR gene transfer into a TCR-deficient
ß T cell
showed that besides the TCR, no other components unique to 
T
cells are needed. Furthermore, interactions between only the T cells
and pE50Y50 were sufficient to bring about the
response. Thus, pE50Y50 elicited a response
distinct from those of T cells to processed/presented peptides or
superantigens, consistent with a mechanism of Ig-like ligand
recognition of 
T cells. Direct stimulation by ligands resembling
pE50Y50 may thus selectively evoke
contributions of 
T cells to the host
response.
This article has been cited by other articles:
![]() |
Y. Ziv, A. Finkelstein, Y. Geffen, J. Kipnis, I. Smirnov, S. Shpilman, I. Vertkin, M. Kimron, A. Lange, T. Hecht, et al. A Novel Immune-Based Therapy for Stroke Induces Neuroprotection and Supports Neurogenesis Stroke, February 1, 2007; 38(2): 774 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Odyniec, M. Szczepanik, M. P. Mycko, M. Stasiolek, C. S. Raine, and K. W. Selmaj {gamma}{delta} T Cells Enhance the Expression of Experimental Autoimmune Encephalomyelitis by Promoting Antigen Presentation and IL-12 Production J. Immunol., July 1, 2004; 173(1): 682 - 694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |